DarioHealth Corp.

DRIO

DarioHealth Corp.

DRIO

Insider Sentiment (TTM):

Last Purchase:2025-08-27Last Sale:2023-01-13Shares Purchased (TTM):40,000Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:842,606Shares Outstanding:6,582,297Institutional Ownership Pct.:12.80%

Earnings Market Reaction:

Filing Date:2026-08-11Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	7	15	22	32	22	28	28	16	23	34	37	44
Short Term Investments	7	5	-	-	-	-	-	-	-	-	-	-
Restricted Investments Current	0	0	0	0	0	0	0	1	1	1	0	0
Accounts And Other Receivables Net Current	2	2	2	2	3	3	5	5	7	8	3	5
Inventory Net	4	4	4	5	5	5	5	5	5	5	5	5
Prepaid Expense And Other Assets Current	3	2	2	3	3	3	2	3	4	4	2	2
Assets Current	22	29	35	42	32	39	41	30	39	53	47	56
Assets Noncurrent
Deposits Assets Noncurrent	0	0	0	0	0	0	0	0	0	0	0	0
Operating Lease Right Of Use Asset	1	1	1	1	1	1	1	1	2	2	1	1
Property Plant And Equipment Net	1	1	1	1	1	1	1	1	1	1	1	1
Intangible Assets Net Excluding Goodwill	15	15	16	16	17	18	19	20	22	24	5	7
Goodwill	57	57	57	57	57	57	57	57	57	57	42	42
Assets Noncurrent	74	75	75	76	76	77	78	80	83	84	49	50
Assets	97	103	110	118	108	116	119	110	122	137	96	107
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Trade Current	3	3	3	3	3	3	3	3	3	4	1	2
Contract With Customer Liability Current	1	1	1	1	1	1	2	1	2	2	1	1
Operating Lease Liability Current	1	0	0	0	1	0	1	1	1	1	0	0
Other Accounts Payable And Accrued Liabilities	5	5	5	5	5	4	6	6	6	7	6	5
Long Term Debt Current	-	-	-	-	-	10	5	9	5	4	4	-
Liabilities Current	10	9	9	9	10	19	17	19	17	18	12	8
Liabilities Noncurrent
Operating Lease Liability Noncurrent	1	1	1	1	1	1	1	1	1	1	1	1
Long Term Debt Noncurrent	31	31	31	31	30	19	23	20	23	25	25	29
Derivative Liabilities Noncurrent	0	0	1	2	3	3	6	11	12	16	0	1
Other Liabilities Noncurrent	0	0	0	0	0	0	0	0	0	0	0	0
Liabilities Noncurrent	32	32	33	34	35	23	30	33	37	41	26	30
Statement Of Stockholders…
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	523	523	520	517	487	478	462	437	432	437	408	402
Retained Earnings Accumulated Deficit	-468	-460	-452	-442	-423	-404	-390	-378	-363	-359	-349	-334
Stockholders Equity	55	62	68	75	64	74	72	59	68	78	58	68
Liabilities And Stockholders Equity	97	103	110	118	108	116	119	110	122	137	96	107
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	400	400	400	400	160	160	400	160	160	160	160	160
Common Stock Shares Issued	7	7	7	7	2	2	2	2	2	1	1	1
Shares Outstanding	7	7	7	7	2	2	2	2	2	1	1	1
Preferred Stock Par Or Stated Value Per Share	-	-	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Authorized	-	-	5	5	5	5	5	5	5	5	5	5
Preferred Stock Shares Issued	-	-	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	-	-	0	0	0	0	0	0	0	0	0	0

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-7.41%	-10.12%	-11.11%	-	-	-	-	-	-	-	-	-
2025	6.21%	6.82%	-16.67%	12.15%	91.00%	63.43%	19.35%	6.05%	1.01%	-12.01%	-5.22%	-8.98%
2024	-29.19%	-36.76%	-50.27%	-2.99%	27.54%	16.17%	-18.66%	-28.35%	-27.73%	-16.54%	11.77%	6.56%
2023	-	-	-	-	-	-	5.94%	65.35%	127.72%	-24.18%	24.18%	-24.18%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	2.31	3.07	3.76	4.55	3.30	2.01	2.44	1.57	2.26	2.95	3.79	6.93
Quick Ratio	1.65	2.40	3.05	3.72	2.54	1.63	2.01	1.13	1.75	2.43	3.22	6.02
Working Capital	12.55M	19.38M	25.74M	32.91M	22.42M	19.41M	23.89M	10.68M	21.92M	34.71M	34.84M	48.11M
Leverage & Debt
Debt to Equity	0.75	0.66	0.62	0.57	0.69	0.57	0.65	0.88	0.79	0.76	0.66	0.57
Interest Coverage TTM	6.02	8.29	12.14	34.37	-	-	-	-	-	-	-	-
Debt Ratio	0.43	0.40	0.38	0.36	0.41	0.36	0.39	0.47	0.44	0.43	0.40	0.36
Efficiency & Turnover
Asset Turnover TTM	0.20	0.19	0.20	0.22	0.24	0.22	0.25	0.21	0.16	0.16	0.19	0.20
Per Share Metrics
Diluted EPS TTM	3.82	6.19	10.47	13.48	17.80	18.91	17.43	23.46	25.51	31.23	41.89	40.09
Free Cash Flow Per Share TTM	-2.73	-3.86	-6.55	-8.58	-10.85	-13.61	-15.78	-19.48	-20.54	-22.82	-21.83	-21.88
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	58.15%	56.55%	56.64%	56.86%	54.98%	52.50%	49.06%	39.90%	30.97%	27.56%	29.40%	36.46%
Operating Profit Margin TTM	151.60%	163.06%	163.94%	160.77%	155.84%	175.85%	213.55%	261.54%	333.25%	323.65%	276.09%	216.54%
Net Profit Margin TTM	169.87%	192.23%	186.56%	171.09%	162.73%	159.80%	158.09%	205.62%	265.33%	282.38%	292.00%	245.31%
Growth Metrics
Net Revenue Growth (1Y)	-22.65%	-24.41%	-17.31%	7.29%	41.79%	47.21%	32.86%	-2.09%	-28.11%	-28.58%	-26.41%	-12.39%
Net Income Growth (1Y)	-19.26%	-9.07%	-2.42%	-10.73%	-13.04%	-16.69%	-28.07%	-17.93%	-11.89%	-9.01%	-4.45%	-21.06%
EPS Growth (1Y)	-78.56%	-67.28%	-39.93%	-42.51%	-30.21%	-39.43%	-58.38%	-41.49%	-37.65%	-27.17%	-20.40%	-37.06%
Valuation Metrics
P/E TTM	1.73	1.30	1.09	1.29	0.75	0.65	0.90	0.96	0.93	0.98	0.82	1.64
P/B TTM	1.12	0.85	0.67	0.73	0.52	0.39	0.54	0.77	0.70	0.68	0.84	1.39
P/S TTM	2.94	2.49	2.03	2.20	1.22	1.03	1.43	1.96	2.48	2.77	2.40	4.01
Market Cap	61.67M	52.79M	45.33M	54.45M	33.25M	28.99M	38.54M	45.27M	47.40M	52.70M	48.80M	94.52M
Enterprise Value	86.10M	68.74M	54.27M	53.16M	41.80M	30.33M	39.70M	57.91M	52.43M	46.12M	40.55M	79.29M
Calculated Values
Free Cash Flow TTM	-25.48M	-25.44M	-26.08M	-26.92M	-26.92M	-32.24M	-38.70M	-39.37M	-40.91M	-39.30M	-30.96M	-31.52M
Net Debt	24.43M	15.95M	8.94M	-1.29M	8.55M	1.34M	1.16M	12.65M	5.03M	-6.58M	-8.25M	-15.22M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-08-27Purchase

Owner: Nelson, Steven Charles

Title: President and CCO

Shares: 40,000

Price/Share: $0.53

Value: $21,200.00

Shares Owned: 95,000

Relationship: Officer

Ownership: Direct

2024-11-12Purchase

Owner: Nelson, Steven Charles

Title: Chief Commercial Officer

Shares: 5,000

Price/Share: $0.91

Value: $4,550.00

Shares Owned: 55,000

Relationship: Officer

Ownership: Direct

2024-09-11Purchase

Owner: Nelson, Steven Charles

Title: Chief Commercial Officer

Shares: 5,000

Price/Share: $0.80

Value: $4,000.00

Shares Owned: 50,000

Relationship: Officer

Ownership: Direct

2024-09-09Purchase

Owner: Nelson, Steven Charles

Title: Chief Commercial Officer

Shares: 5,000

Price/Share: $0.80

Value: $4,000.00

Shares Owned: 40,000

Relationship: Officer

Ownership: Direct

2024-08-27Purchase

Owner: Raphael, Erez

Title: Chief Executive Officer

Shares: 5,000

Price/Share: $0.88

Value: $4,400.00

Shares Owned: 1,937,059

Relationship: Director,Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-08-27	Nelson, Steven Charles	Officer	President and CCO	Direct	Purchase	40,000	0.53	$21,200.00	95,000	4
2024-11-12	Nelson, Steven Charles	Officer	Chief Commercial Officer	Direct	Purchase	5,000	0.91	$4,550.00	55,000	4
2024-09-11	Nelson, Steven Charles	Officer	Chief Commercial Officer	Direct	Purchase	5,000	0.80	$4,000.00	50,000	4
2024-09-09	Nelson, Steven Charles	Officer	Chief Commercial Officer	Direct	Purchase	5,000	0.80	$4,000.00	40,000	4
2024-08-27	Raphael, Erez	Director,Officer	Chief Executive Officer	Direct	Purchase	5,000	0.88	$4,400.00	1,937,059	4
2024-08-23	Nelson, Steven Charles	Officer	Chief Commercial Officer	Direct	Purchase	5,000	0.95	$4,750.00	25,000	4
2024-08-21	Raphael, Erez	Director,Officer	Chief Executive Officer	Direct	Purchase	5,000	0.95	$4,750.00	1,932,059	4
2024-08-20	Nelson, Steven Charles	Officer	Chief Commercial Officer	Direct	Purchase	5,000	0.94	$4,700.00	10,000	4
2024-08-19	Raphael, Erez	Director,Officer	Chief Executive Officer	Direct	Purchase	5,000	0.90	$4,500.00	1,922,059	4
2023-01-13	Raphael, Erez	Director,Officer	Chief Executive Officer	Direct	Sale	1,200	6.21	$7,452.00	1,112,059	4
2022-12-21	Mcgrath, Dennis M	Director	-	Direct	Sale	9,872	3.97	$39,191.84	74,744	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

12.80%

Inst. Shares: 842,606

Shares Outstanding: 6,582,297

2025-12-31

18.46%

Inst. Shares: 735,327

Shares Outstanding: 3,982,956

2025-09-30

25.04%

Inst. Shares: 785,647

Shares Outstanding: 3,138,106

2025-06-30

283.75%

Inst. Shares: 7,041,407

Shares Outstanding: 2,481,547

2025-03-31

Inst. Shares: 7,340,779

Shares Outstanding: 2,368,516

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	842,606	6,582,297	12.80%
2025-12-31	735,327	3,982,956	18.46%
2025-09-30	785,647	3,138,106	25.04%
2025-06-30	7,041,407	2,481,547	283.75%
2025-03-31	7,340,779	2,368,516	-
2024-12-31	7,746,055	2,451,971	-
2024-09-30	7,511,126	2,020,872	-
2024-06-30	7,666,722	1,991,540	-
2024-03-31	8,147,765	1,722,129	-
2023-12-31	7,694,114	1,418,599	-
2023-09-30	9,055,367	1,440,780	-
2023-06-30	7,941,956	1,409,317	-
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

DarioHealth Corp. (DRIO) — SEC Financial Statements & Analysis

DarioHealth Corp. (DRIO) is a surgical & medical instruments & apparatus company, incorporated in DE. DarioHealth Corp. trades on Nasdaq as: DRIO. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), DarioHealth Corp. reported a -22.65% year-over-year revenue growth, a Gross Profit Margin of 58.15% (TTM), a Debt-to-Equity ratio of 0.75x, a Price-to-Sales (P/S) ratio of 2.94x (TTM), a Price-to-Book (P/B) ratio of 1.12x (TTM), at a market cap of $61.67M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -22.65%
Gross Profit Margin TTM: 58.15%
Debt To Equity: 0.75x
P/S TTM: 2.94x
P/B TTM: 1.12x
Market Cap: $61.67M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is DarioHealth Corp. in?

DarioHealth Corp. (DRIO) operates in the Surgical & Medical Instruments & Apparatus industry.

What is DRIO's market cap?

DarioHealth Corp. (DRIO) has a market capitalization of $61.67M as of 2026-06-30.

What is DRIO's P/E ratio?

DarioHealth Corp. (DRIO)'s trailing twelve month P/E ratio is 1.73x as of 2026-06-30.

What exchange does DRIO trade on?

DarioHealth Corp. (DRIO) trades on the Nasdaq.

Where is DarioHealth Corp. incorporated?

DarioHealth Corp. is incorporated in DE.